To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Oak HC/FT backs Infusion for Health, eyeing larger chronic disease management opportunity
The firm leads a $50m investment in the LA-based ambulatory infusion platform, whose run-rate revenue is currently north of $100m and expanding rapidly on top of that.
